Drug intelligence / Profile preview

VRP-1024

Development stage: Preclinical
Lead developer: Venus Medicine Research Centre
Administration: Oral

Overview

VRP-1024 is a preclinical-stage herbal product being developed by the Venus Medicine Research Centre (VMRC). It is formulated as an oral tablet. As of the current pipeline status, the specific active ingredients, biological targets, and therapeutic indications for VRP-1024 remain undisclosed by the sponsor. The development program has completed the formulation and development (F&D) stage, and preclinical studies are currently ongoing.

Beyond the preview

Go deeper on VRP-1024.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VRP-1024.

Explore the full profile